Skip to content
Curia
  • Contact Us
  • Events
  • News & Updates
  • Careers
  • Small Molecule
    • Discovery
      • Assay Development & Screening
      • Cell-Based Assay Development and Testing
      • Computer Aided Drug Design (CADD)
      • Custom Synthesis
      • DMPK
      • In Vitro Biology
      • Integrated Drug Discovery
      • Medicinal Chemistry
      • Protein Expression & Analysis
      • Structural Biology
    • Development & Manufacturing
      • API Manufacturing
      • Chemical Process R&D
      • Fermentation Expertise
      • Flow Chemistry
      • GMP Controlled Substance
      • High Potency
      • Solid Form Development
      • Sterile API Manufacturing
      • Steroids & Hormones
      • Regulatory Support
    • Fine Chemicals
      • 4-Formylphenyl Boronic Acid (4-FPBA)
      • Gemagique® AMPS Polymers
      • Oxa Acids
      • Propane-phosphonic Acid Anhydride – T3P® Reagent
      • Vinylphosphonic Acid (VPA)
  • Generic APIs
    • API Catalog
    • Intellectual Property Services
  • Biologics
    • Discovery
      • Antibody Discovery & Engineering
      • Antibody Developability Analysis
      • Molecular Biology
      • Recombinant Antibody Production
      • Recombinant Protein Production
      • Cell Engineering
      • Bioanalytical Assays
      • Biological and Functional Assays
    • Development
      • Mammalian
        • Cell Line Development
        • Upstream Process Development
        • Downstream Process Development
      • mRNA
        • DNA Services
        • mRNA Process Development
        • mRNA Analytical Services
      • Baculovirus Expression Vector System (BEVS)
    • Manufacturing
      • GMP Mammalian Drug Substance Manufacturing
      • GMP mRNA Manufacturing
      • LNP Formulation
      • Analytical Testing & Release
      • Quality Systems
      • Biorepository Service
  • Sterile Drug Product
    • Drug Product Development
      • Formulation Development
      • Process Development
    • Clinical Manufacturing
    • Commercial Manufacturing
  • Analytical Testing
    • Batch Release & Stability
    • Method Development & Validation
    • Solid State Chemistry
  • Insights
  • About Us
    • Team
    • Corporate Responsibility
    • Partnering with Us
    • Strategic Government Partnerships
    • Facilities
    • Events
    • News & Updates
Home | Uncategorized

October 27, 2025

Curia Invests $4 Million to Enhance Sterile API Manufacturing

  • Abby Sorensen
  • Posted in Uncategorized

Albany, NY- October 27, 2025 – Curia, a leading global research, development and manufacturing organization, today announced the completion of...

  • Curia Small Molecule
    • Discovery
    • Development
    • Manufacturing
    • Fine Chemicals
  • Curia Generic APIs
    • API Catalog
    • Intellectual Property Services
  • Curia Biologics
    • Discovery
    • Development
    • Manufacturing
  • Curia Sterile Drug Product
    • Development
    • Clinical Manufacturing
    • Commercial Manufacturing
  • Insights
  • About Us
  • Contact Us
  • Supplier Information
  • Events
  • Careers
  • Linkedin
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms of Use
  • Terms & Conditions
© 2026 Curia Global, Inc.